Pharmacological Management of Chronic Neuropathic Pain: Revised Consensus Statement from the Canadian Pain Society
Open accessThe DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Neuropathic pain (NeP), redefined as pain caused by a lesion or a disease of the somatosensory system, is a disabling condition that affects approximately two million Canadians. OBJECTIVE: To review the randomized controlled trials (RCTs) and systematic reviews related to the pharmacological management of NeP to develop a revised evidence‐based consensus statement on its management. METHODS: RCTs, systematic reviews and existing guidelines on the pharmacological management of NeP were evaluated at a consensus meeting in May 2012 and updated until September 2013. Medications were recommended in the consensus statement if their analgesic efficacy was supported by at least one methodologically sound RCT (class I or class II) showing significant benefit relative to placebo or another relevant control group. Recommendations for treatment were based on the degree of evidence of analgesic efficacy, safety and ease of use. RESULTS: Analgesic agents recommended for first‐line treatments are gabapentinoids (gabapentin and pregabalin), tricyclic antidepressants and serotonin noradrenaline reuptake inhibitors. Tramadol and controlled‐release opioid analgesics are recommended as second‐line treatments for moderate to severe pain. Cannabinoids are now recommended as third‐line treatments. Recommended fourth‐line treatments include methadone, anticonvulsants with lesser evidence of efficacy (eg, lamotrigine, lacos‐amide), tapentadol and botulinum toxin. There is support for some analgesic combinations in selected NeP conditions. CONCLUSIONS: These guidelines provide an updated, stepwise approach to the pharmacological management of NeP. Treatment should be individualized for each patient based on efficacy, side‐effect profile and drug accessibility, including cost. Additional studies are required to examine head‐to‐head comparisons among analgesics, combinations of analgesics, long‐term outcomes and treatment of pediatric, geriatric and central NeP.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Results from both the scientific literature and public media revealed few references to nabilone abuse.”
From Nabilone for the Management of Pain (2016) · cites this paper as [32]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“However, nabilone theft did occur, although nabilone has no known street value.”
From Nabilone for the Management of Pain (2016) · cites this paper as [32]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“According to the literature, the positive side effects (euphoria, mood elevation) of nabilone, which may lead to abuse, generally occurred less frequently than the negative side effects (drowsiness, dizziness, and dry mouth).”
From Nabilone for the Management of Pain (2016) · cites this paper as [32]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In the public media, patients described nabilone as not producing the same therapeutic and recreational effects as smoked cannabis.”
From Nabilone for the Management of Pain (2016) · cites this paper as [32]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Overall, the authors concluded that nabilone is rarely abused or diverted.”
From Nabilone for the Management of Pain (2016) · cites this paper as [32]
Experimental — accuracy not yet measured
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Treede (2008) · doi:10.1212/01.wnl.0000282763.29778.59 · Cited by 2,746
Bouhassira, D., Attal, N., Alchaar, H., Boureau, F., Brochet, B., Bruxelle, J., Cunin, G., Fermanian, J., Ginies, P., Grun-Overdyking, A., et al. (2005) · Pain · doi:10.1016/j.pain.2004.12.010 · Cited by 2,741
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
Attal, N., Cruccu, G., Baron, R., Haanpää, M., Hansson, P., Jensen, T. S., & Nurmikko, T. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.02999.x · Cited by 1,873
Prevalence of chronic pain with neuropathic characteristics in the general population
Bouhassira, D., Lantéri-Minet, M., Attal, N., Laurent, B., & Touboul, C. (2008) · Pain · doi:10.1016/j.pain.2007.08.013 · Cited by 1,745
Algorithm for neuropathic pain treatment: An evidence based proposal
Finnerup, N. B., Otto, M., McQuay, H. J., Jensen, T. S., & Sindrup, S. H. (2005) · Pain · doi:10.1016/j.pain.2005.08.013 · Cited by 1,330
Effects of Desipramine, Amitriptyline, and Fluoxetine on Pain in Diabetic Neuropathy
Max, M. B., Lynch, S. A., Muir, J., Shoaf, S. E., Smoller, B., & Dubner, R. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205073261904 · Cited by 1,117
The evidence for pharmacological treatment of neuropathic pain
Finnerup, N. B., Sindrup, S. H., & Jensen, T. S. (2010) · Pain · doi:10.1016/j.pain.2010.06.019 · Cited by 1,045
Smith, E. M. L., Pang, H., Cirrincione, C., Fleishman, S., Paskett, E. D., Ahles, T., Bressler, L. R., Fadul, C. E., Knox, C., Le-Lindqwister, N., et al. (2013) · JAMA · doi:10.1001/jama.2013.2813 · Cited by 1,014
Torrance, N., Smith, B. H., Bennett, M. I., & Lee, A. J. (2006) · The Journal of Pain · doi:10.1016/j.jpain.2005.11.008 · Cited by 1,000
A systematic review of antidepressants in neuropathic pain
McQuay, H. J., Tramér, M., Nye, B. A., Carroll, D., Wiffen, P. J., & Moore, R. A. (1996) · Pain · doi:10.1016/s0304-3959(96)03140-5 · Cited by 930
Research works printed but not linked: 1
- [20]Cohen J Statistical Power Analysis for the Behavioural Sciences New York, San Francisco, London Academic Press 1988
Cited by
Items 101–200 of 529
Samineni, V. K., Premkumar, L. S., & Faingold, C. L. (2017) · Pain · doi:10.1097/j.pain.0000000000000905 · Cited by 60
Guideline No. 445: Management of Chronic Pelvic Pain
Allaire, C., Yong, P. J., Bajzak, K., Jarrell, J., Lemos, N., Miller, C., Morin, M., Nasr-Esfahani, M., Singh, S. S., & Chen, I. (2024) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2023.102283 · Cited by 53
Managing Chronic Neuropathic Pain: Recent Advances and New Challenges
Hange, N., Poudel, S., Ozair, S., Paul, T., Nambakkam, M., Shrestha, R., Greye, F., Shah, S., Adhikari, Y. R., Thapa, S., et al. (2022) · Neurology Research International · doi:10.1155/2022/8336561 · Cited by 67
Pain in primary Sjögren's syndrome
Vitali, C., & Papa, N. D. (2015) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2015.05.002 · Cited by 57
Peripheral Neuropathy under Oncologic Therapies: A Literature Review on Pathogenetic Mechanisms
Laforgia, M., Laface, C., Calabrò, C., Ferraiuolo, S., Ungaro, V., Tricarico, D., Gadaleta, C. D., Nardulli, P., & Ranieri, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041980 · Cited by 63
Pharmacotherapy of Neuropathic Pain: Time To Rewrite The Rulebook?
Finnerup, N. B., & Attal, N. (2015) · Pain Management · doi:10.2217/pmt.15.53 · Cited by 60
Farmer, A. D., Gallagher, J., Holt, C. E. M. B., & Aziz, Q. (2017) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(16)30217-5 · Cited by 54
Affective Circuitry Alterations in Patients with Trigeminal Neuralgia
Hayes, D. J., Chen, D. Q., zhong, J., Lin, A., Behan, B., Walker, M., & Hodaie, M. (2017) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2017.00073 · Cited by 54
Cannabis and cannabinoids in cancer pain management
Meng, H., Dai, T., Hanlon, J. G., Downar, J., Alibhai, S. M. H., & Clarke, H. A. (2020) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0000000000000493 · Cited by 62
Self-citationCentral Neuropathic Pain Syndromes: Current and Emerging Pharmacological Strategies
Gurba, K. N., Chaudhry, R., & Haroutounian, S. (2022) · CNS Drugs · doi:10.1007/s40263-022-00914-4 · Cited by 52
MacCallum, C. A., Eadie, L., Barr, A. M., Boivin, M. R., & Lu, S. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.633168 · Cited by 77
Antidepressants for chronic non-cancer pain in children and adolescents
Cooper, T. E., Heathcote, L. C., Clinch, J., Gold, J. I., Howard, R. F., Lord, S. M., Schechter, N. L., Wood, C. H., & Wiffen, P. J. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012535 · Cited by 48
Neuropathic Pain in Neurologic Disorders: A Narrative Review
Mitsikostas, D. D., Μoka, Ε., Orrillo, E., Aurilio, C., Vadalouca, A., Paladini, A., & Varrassi, G. (2022) · Cureus · doi:10.7759/cureus.22419 · Cited by 69
Phosphorylated CRMP2 Regulates Spinal Nociceptive Neurotransmission
Yu, J., Moutal, A., Dorame, A., Bellampalli, S. S., Chefdeville, A., Kanazawa, I., Pham, N. Y. N., Park, K. D., Weimer, J. M., & Khanna, R. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1445-6 · Cited by 46
Stroman, P. W., Khan, H. S., Bosma, R. L., Cotoi, A. I., Leung, R. H., Cadotte, D. W., & Fehlings, M. G. (2016) · Journal of Neurotrauma · doi:10.1089/neu.2015.4257 · Cited by 49
Provoked vestibulodynia: current perspectives
Henzell, H., Berzins, K., & Langford, J. (2017) · International Journal of Women's Health · doi:10.2147/ijwh.s113416 · Cited by 44
Mallick‐Searle, T., & Adler, J. A. (2024) · Journal of Pain Research · doi:10.2147/jpr.s442595 · Cited by 57
Assessment and management of post‐COVID fatigue
Gaber, T. (2021) · Progress in Neurology and Psychiatry · doi:10.1002/pnp.698 · Cited by 48
Mendlik, M. T., & Uritsky, T. J. (2015) · Current Treatment Options in Neurology · doi:10.1007/s11940-015-0381-2 · Cited by 58
Antidepressants for pain management in adults with chronic pain: a network meta-analysis
Birkinshaw, H., Friedrich, C., Cole, P., Eccleston, C., Serfaty, M. A., Stewart, G. B., White, S. J., Moore, A., Phillippo, D., & Pincus, T. (2024) · Health Technology Assessment · doi:10.3310/mkrt2948 · Cited by 54
Glycine transporter inhibitors: A new avenue for managing neuropathic pain
Al‐Khrasani, M., Mohammadzadeh, A., Balogh, M., Király, K. P., Barsi, S., Hajnal, B., Köles, L., Zádori, Z., & Hársing, L. G. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.07.008 · Cited by 45
Reyad, R. M., Shaker, E. H., Ghobrial, H. Z., Abbas, D. N., Reyad, E. M., Alrahman, A. A. M. A., Al-Demery, A., & Issak, E. R. (2019) · European Journal of Pain · doi:10.1002/ejp.1473 · Cited by 46
Duration of Neurocognitive Impairment With Medical Cannabis Use: A Scoping Review
Eadie, L., Lo, L. A., Christiansen, A. L., Brubacher, J. R., Barr, A. M., Panenka, W. J., & MacCallum, C. A. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.638962 · Cited by 48
Nonpharmacological therapies for central poststroke pain
Xu, X., Luo, H., Rong, B., Zheng, X.-M., Wang, F.-T., Zhang, S., & Li, Z. (2020) · Medicine · doi:10.1097/md.0000000000022611 · Cited by 41
An update on the pharmacologic management and treatment of neuropathic pain
Wright, M. E., & Rizzolo, D. (2017) · JAAPA · doi:10.1097/01.jaa.0000512228.23432.f7 · Cited by 48
Milnacipran for neuropathic pain in adults
Derry, S., Phillips, T., Moore, A., & Wiffen, P. J. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011789 · Cited by 40
Emerging drugs for diabetic peripheral neuropathy and neuropathic pain
Παπάνας, Ν., & Ziegler, D. (2016) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2016.1257605 · Cited by 42
Neuropathic Pain in Taxane-Induced Peripheral Neuropathy: Evidence for Exercise in Treatment
Hammond, E. A., Pitz, M. W., & Shay, B. L. (2019) · Neurorehabilitation and neural repair · doi:10.1177/1545968319860486 · Cited by 46
Falk, J., Thomas, B., Kirkwood, J. E. M., Korownyk, C. S., Lindblad, A. J., Ton, J., Moe, S., Allan, G. M., McCormack, J. P., Garrison, S., et al. (2021) · Canadian Family Physician · doi:10.46747/cfp.6705e130 · Cited by 41
Zhu, C., Lan, X., Wei, Z., Yu, J., & Zhang, J. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.07.020 · Cited by 42
Reyad, R. M., Omran, A. F., Abbas, D. N., Kamel, M. A., Shaker, E., Tharwat, J., Reyad, E. M., & Hashem, T. (2018) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2018.10.496 · Cited by 43
Cao, X., Chen, Y., Zhang, Y., Lan, Y., Zhang, J., Xu, X., Qiu, Y., Zhao, S., Liu, X., Liu, B., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01416 · Cited by 39
Overlaps in pharmacology for the treatment of chronic pain and mental health disorders
Sutherland, A. M., Nicholls, J., Bao, J., & Clarke, H. A. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.07.017 · Cited by 40
Self-citationRole of microglia in neuropathic pain
Karavis, M. Y., Siafaka, I., Vadalouca, A., & Georgoudis, G. (2023) · Cureus · doi:10.7759/cureus.43555 · Cited by 53
Dosenovic, S., Jelicic Kadic, A., Vucic, K., Markovina, N., Pieper, D., & Puljak, L. (2018) · BMC Medical Research Methodology · doi:10.1186/s12874-018-0493-y · Cited by 36
Mo, Y., Liu, B., Qiu, S., Wang, X., Zhong, L., Han, X., & Mi, F. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.14998 · Cited by 36
Preparation and characterization of ethylcellulose microspheres for sustained-release of pregabalin
Yasin, H. K. A., Al-Taani, B., & Sheikh-Salem, M. (2020) · Research in Pharmaceutical Sciences · doi:10.4103/1735-5362.305184 · Cited by 41
Feng, X., Niu, L., Meng, L., Luo, K., Huang, X., Chen, M., Lin, Z., Zhou, W., Yi, S., & Ao, L. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/6510383 · Cited by 37
Jeanson, T., Duchêne, A., Richard, D., Bourgoin, S., Picoli, C., Ezan, P., Mouthon, F., Giaume, C., Hamon, M., & Charvériat, M. (2016) · Scientific Reports · doi:10.1038/srep38766 · Cited by 37
Cannabinoids and the Gastrointestinal Tract
Camilleri, M., & Zheng, T. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.07.031 · Cited by 48
Moulin, D. E., Morley-Forster, P., Pirani, Z., Rohfritsch, C., & Stitt, L. (2019) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-019-01395-8 · Cited by 39
Self-citationNew Vistas in microRNA Regulatory Interactome in Neuropathic Pain
Gada, Y., Pandey, A., Jadhav, N., Ajgaonkar, S., Mehta, D. S., & Nair, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.778014 · Cited by 35
Clarke, H. (2016) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2016.1129896 · Cited by 33
Self-citationBugden, S., Friesen, K. J., Falk, J., Alessi‐Severini, S., & Chateau, D. (2016) · Journal of Pain Research · doi:10.2147/jpr.s107944 · Cited by 33
Kwok, H., Khuu, W., Fernandes, K. A., Martins, D., Tadrous, M., Singh, S., Juurlink, D. N., & Gomes, T. (2016) · Pain Medicine · doi:10.1093/pm/pnw351 · Cited by 35
Are Opioids Effective in Relieving Neuropathic Pain?
Schembri, E. (2018) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-018-0009-4 · Cited by 38
Treatment Patterns and Medication Use in Patients with Postherpetic Neuralgia
Gudin, J. A., Fudin, J., Wang, E., Haylon, T., Patel, K., & Goss, T. F. (2019) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2019.19093 · Cited by 32
The Anti-Allodynic Gabapentinoids: Myths, Paradoxes, and Acute Effects
Alles, S. R. A., & Smith, P. A. (2016) · The Neuroscientist · doi:10.1177/1073858416628793 · Cited by 48
Luu, W., Bjork, J. A., Salo, E., Entenmann, N., Jurgenson, T., Fisher, C., & Klein, A. H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092251 · Cited by 31
Schneider, T., Zurbriggen, L., Dieterle, M., Mauermann, E., Frei, P., Mercer‐Chalmers‐Bender, K., & Ruppen, W. (2021) · Pain · doi:10.1097/j.pain.0000000000002310 · Cited by 35
Strand, N. H., Wie, C. S., Peck, J., Maita, M., Singh, N., Dumbroff, J., Francio, V. T., Murphy, M. T., Chang, K., Dickerson, D. M., et al. (2022) · Current Pain and Headache Reports · doi:10.1007/s11916-022-01044-8 · Cited by 36
Vojnits, K., Mahammad, S., Collins, T. J., & Bhatia, M. (2019) · Stem Cells Translational Medicine · doi:10.1002/sctm.19-0054 · Cited by 30
Borgonetti, V., & Galeotti, N. (2022) · Pain · doi:10.1097/j.pain.0000000000002807 · Cited by 34
Self-management of pain and depression in adults with spinal cord injury: A scoping review
Cadel, L., DeLuca, C., Hitzig, S. L., Packer, T. L., Lofters, A., Patel, T., & Guilcher, S. J. T. (2018) · Journal of Spinal Cord Medicine · doi:10.1080/10790268.2018.1523776 · Cited by 32
Long-term efficacy of immunoglobulins in small fiber neuropathy related to Sjögren’s syndrome
Sala, T. P., Villedieu, M., Damian, L. O., Crave, J., Pautot, V., Stojanovich, L., Tervaert, J. W. C., Cherin, P., & Belizna, C. C. (2020) · Journal of Neurology · doi:10.1007/s00415-020-10033-z · Cited by 30
Neuropathic Pain and Sickle Cell Disease: a Review of Pharmacologic Management
Orhurhu, M. S., Chu, R., Claus, L. E., Roberts, J. S., Salisu, B., Urits, I., Orhurhu, E., Viswanath, O., Kaye, A. D., Kaye, A. J., et al. (2020) · Current Pain and Headache Reports · doi:10.1007/s11916-020-00885-5 · Cited by 29
Wei, M., Li, L., Zhang, Y., Zhang, M., & Su, Z. Z. (2020) · Gene · doi:10.1016/j.gene.2020.145038 · Cited by 29
Borgonetti, V., & Galeotti, N. (2022) · Biomedicines · doi:10.3390/biomedicines10071468 · Cited by 32
Medical Cannabis in the Palliation of Malignant Wounds—A Case Report
Maida, V. (2016) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2016.09.003 · Cited by 28
Rates and Correlates of Pain Specialty Clinic Use Nationally in the Veterans Health Administration
Arout, C. A., Sofuoglu, M., & Rosenheck, R. A. (2017) · Pain Medicine · doi:10.1093/pm/pnw206 · Cited by 28
The Peripheral Nerve Surgeon’s Role in the Management of Neuropathic Pain
Caragher, S. P., Khouri, K. S., Raasveld, F. V., Winograd, J. M., Valerio, I. L., Gfrerer, L., & Eberlin, K. R. (2023) · Plastic & Reconstructive Surgery Global Open · doi:10.1097/gox.0000000000005005 · Cited by 34
Adcock, S., & Tucker, C. B. (2018) · Elsevier eBooks · doi:10.1016/b978-0-08-100938-3.00008-5 · Cited by 31
Liu, H., Lü, F., Zhou, D., Yin, Y., Li, J., Yang, B., Song, L., Ye, L., & Xiao, H. (2018) · Clinical Journal of Pain · doi:10.1097/ajp.0000000000000623 · Cited by 29
Xiao, L. (2020) · Pain Physician · doi:10.36076/ppj.2020/23/e219 · Cited by 30
Antidepressants for pain management in adults with chronic pain: a network meta-analysis
Birkinshaw, H., Friedrich, C., Cole, P., Eccleston, C., Serfaty, M. A., Stewart, G. B., White, S. J., Moore, A., & Pincus, T. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014682 · Cited by 28
Bastian, Z. J., & Bastian, R. W. (2015) · PeerJ · doi:10.7717/peerj.816 · Cited by 26
The Challenges of Interstitial Cystitis: Current Status and Future Prospects
Belknap, S. L., Blalock, E. M., & Erickson, D. R. (2015) · Drugs · doi:10.1007/s40265-015-0504-9 · Cited by 26
Balogh, M., Zádor, F., Zádori, Z., Shaqura, M. A., Király, K. P., Mohammadzadeh, A., Varga, B. T., Lázár, B., Mousa, S. A., Hosztafi, S., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00347 · Cited by 27
Tetsunaga, T., Tetsunaga, T., Nishida, K., Misawa, H., Takigawa, T., Yamane, K., Tsuji, H., Takei, Y., & Ozaki, T. (2020) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-020-01709-3 · Cited by 31
Brandl, E., Halford, Z., Clark, M. D., & Herndon, C. M. (2021) · Annals of Pharmacotherapy · doi:10.1177/10600280211003875 · Cited by 30
Na v 1.7 target modulation and efficacy can be measured in nonhuman primate assays
Kraus, R. L., Zhao, F., Pall, P. S., Zhou, D., Vardigan, J. D., Danziger, A., Li, Y., Daley, C., Ballard, J. E., Clements, M. K., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.aay1050 · Cited by 29
Bone Health, Pain, and Mobility: Evidence-Based Recommendations for Patients With Multiple Myeloma
Rome, S., Noonan, K., Bertolotti, P., Tariman, J. D., Miceli, T. S., & and Board (2017) · Clinical journal of oncology nursing · doi:10.1188/17.cjon.s5.47-59 · Cited by 26
Methadone for neuropathic pain in adults
McNicol, E. D., Ferguson, M. C., & Schumann, R. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012499 · Cited by 29
Kamble, S. V., Motlekar, S. A., D'souza, L. L., Kudrigikar, V. N., & Rao, S. E. (2017) · The Korean journal of pain · doi:10.3344/kjp.2017.30.3.183 · Cited by 28
Kampo for the Treatment of Pain in Japan: A Review
Arai, Y.-C. P., Makino, I., Ikemoto, T., Saisu, H., Terajima, Y., & Owari, K. (2020) · Pain and Therapy · doi:10.1007/s40122-020-00160-w · Cited by 28
Status of Analgesic Drugs and Quality of Life Results for Diabetic Peripheral Neuropathy in China
Lian, J., Wang, H., Cui, R., Zhang, C., & Fu, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.813210 · Cited by 26
Positive Allosteric Modulators of Glycine Receptors and Their Potential Use in Pain Therapies
Gallagher, C. I., Ha, D. A., Harvey, R. J., & Vandenberg, R. J. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000583 · Cited by 30
Wu, C.-S., Huang, Y., Ko, Y., & Lee, C. (2023) · Systematic Reviews · doi:10.1186/s13643-023-02185-6 · Cited by 30
GERRARD, D. F., & Pipe, A. (2017) · Medicine and sport science/Medicine and sport · doi:10.1159/000460700 · Cited by 28
The Quest for more Research on Painful Diabetic Neuropathy
Nawroth, P. P., Bendszus, M., Pham, M., Jende, J. M. E., Heiland, S., Ries, S. R., Schumann, C., Schmelz, M., Schuh‐Hofer, S., Treede, R., et al. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.09.023 · Cited by 28
Nakhli, M. S., Kahloul, M., Jebali, C., Frigui, W., & Naija, W. (2018) · Pain Research and Management · doi:10.1155/2018/9834059 · Cited by 24
Kämmerer, P. W., Heimes, D., Hartmann, A., Kesting, M. R., Khoury, F., Schiegnitz, E., Thiem, D. G. E., Wiltfang, J., Al‐Nawas, B., & Kämmerer, W. (2024) · Clinical Oral Investigations · doi:10.1007/s00784-024-05615-4 · Cited by 39
Cannabinoids in Pain Treatment: An Overview
Mallick‐Searle, T., & Marie, B. S. (2019) · Pain Management Nursing · doi:10.1016/j.pmn.2018.12.006 · Cited by 26
The Role of the Pharmacist in the Care of Patients with Chronic Pain
Murphy, L. L., Ng, K., Isaac, P., Swidrovich, J. P., Zhang, M., & Sproule, B. A. (2021) · Integrated Pharmacy Research and Practice · doi:10.2147/iprp.s248699 · Cited by 34
Immunotherapies for Neurological Manifestations in the Context of Systemic Autoimmunity
Kampylafka, E. I., Alexopoulos, H., Dalakas, M. C., & Tzioufas, A. G. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0393-3 · Cited by 24
Topical Treatment of Localized Neuropathic Pain in the Elderly
Pickering, G. P., & Lucchini, C. (2020) · Drugs & Aging · doi:10.1007/s40266-019-00739-9 · Cited by 23
Aly, E., & Masocha, W. (2021) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2021.01.004 · Cited by 23
Li, D., Yoo, J. H., & Kim, S. K. (2020) · Toxins · doi:10.3390/toxins12100620 · Cited by 22
Molecular Mechanisms of Chronic Pain and Therapeutic Interventions
Li, Z., Li, X., Liu, J., Sun, R., Ye, Y., Xiang, H., Luo, F., Li, S., & Luo, A. (2025) · MedComm · doi:10.1002/mco2.70325 · Cited by 36
Slivicki, R. A., Ali, Y., Lu, H., & Hohmann, A. G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147620 · Cited by 23
The use of antineuropathic medications for the treatment of chronic pain
Urits, I., Li, N., Berardino, K., Artounian, K., Bandi, P., Jung, J. W., Kaye, R. J., Manchikanti, L., Kaye, A. M., Simopoulos, T. T., et al. (2020) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2020.08.007 · Cited by 23
Mohammadzadeh, A., Lakatos, P. P., Balogh, M., Zádor, F., Karádi, D. Á., Zádori, Z., Király, K. P., Galambos, A. R., Barsi, S., Riba, P., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052479 · Cited by 22
Scope and Applications of Nanomedicines for the Management of Neuropathic Pain
Kuthati, Y., Rao, V. N., Busa, P., Tummala, S., Naga, G. D. V., & Wong, C. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b01027 · Cited by 20
Johal, H. S., Vannabouathong, C., Chang, Y., Zhu, M. T., & Bhandari, M. (2020) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x20937968 · Cited by 21
Systemic drug therapy for neuropathic pain
Hennemann-Krause, L., & Sredni, S. (2016) · Revista Dor · doi:10.5935/1806-0013.20160057 · Cited by 29
Staudt, M. D., Clark, A. J., GORDON, A. S., Lynch, M. E., Morley-Forster, P. K., Nathan, H., Smyth, C. E., Stitt, L., Toth, C. C., Ware, M. A., et al. (2018) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2018.55 · Cited by 21
Self-citationMedical Cannabis for Chronic Noncancer Pain: A Systematic Review of Health Care Recommendations
Chang, Y., Zhu, M., Vannabouathong, C., Mundi, R., Chou, R. S., & Bhandari, M. (2021) · Pain Research and Management · doi:10.1155/2021/8857948 · Cited by 20
“'e justifications for the recommendations included moderate-quality evidence of positive effects with cannabinoids [23, 29], limited benefits and high risk of harms [26], unclear long-term efficacy and safety due to lack of longterm follow-up data [18, 19], and need of further studies to investigate potential drug int…”
BackgroundInfluentialEmerging targets in treating pain
Chang, D. S., Raghavan, R. S., Christiansen, S., & Cohen, S. P. (2015) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000216 · Cited by 20
Shoaib, R. M., Ahmad, K. A., & Wang, Y. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15471 · Cited by 20
da Silva, M. D. V., Martelossi-Cebinelli, G., Yaekashi, K. M., de Carvalho, T. T., Borghi, S. M., Casagrande, R., & Verri, W. A., Jr. (2024) · Brain Sciences · doi:10.3390/brainsci14060589 · Cited by 22
Metadata
- Authors
- Moulin, D., Boulanger, A., Clark, A., Clarke, H., Dao, T., Finley, G., Furlan, A., Gilron, I., Gordon, A., Morley-Forster, P., Sessle, B., Squire, P., Stinson, J., Taenzer, P., Velly, A., Ware, M., Weinberg, E., & Williamson, O.
- Affiliations
- Victoria Hospital (CA)
- Corresponding author
- Moulin, DE
- Venue
- Pain Research and Management
- Publisher
- Wiley
- Published
- 2014-01
- Volume
- 19
- Issue
- 6
- Pages
- 328-335
- ISSN
- 1203-6765 (ISSN-L)
- 1918-1523
- PMC
- PMC4273712
- OpenAlex
- W2206489433
- Cited by
- 529
- References
- 97
- Citations by year
- 2026: 14 · 2025: 14 · 2024: 54 · 2023: 38 · 2022: 38 · 2021: 58 · 2020: 53 · 2019: 53 · 2018: 52 · 2017: 60 · 2016: 50 · 2015: 43
- FWCI
- 34.23
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Pain Research and Management (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship@McGill (McGill) (submittedVersion, cc-by)
- eScholarship@McGill (McGill) (submittedVersion, other-oa)
- Funders
- Neuropathic Pain Special Interest Group of the CPS
- Topics
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Treatment
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Keywords
- neuropathic pain, pharmacological management, gabapentinoids, pregabalin, tricyclic antidepressants, serotonin-norepinephrine reuptake inhibitors, tramadol, controlled-release opioids, cannabinoids, methadone, antiepileptic drugs, tapentadol, botulinum toxin, analgesic combination, stepwise treatment, analgesic efficacy and safety
- MeSH terms
- Analgesics, Canada, Humans, Neuralgia, Chronic Pain, Pain Management
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.